skip to main content
10.1145/3107411.3107473acmconferencesArticle/Chapter ViewAbstractPublication PagesbcbConference Proceedingsconference-collections
short-paper

A Flexible and Robust Multi-Source Learning Algorithm for Drug Repositioning

Published: 20 August 2017 Publication History

Abstract

Drug repositioning is a promising strategy in drug discovery. New biomedical insights of drug-target-disease relationships are important in drug repositioning, and such relationships have been intensively studied recently. Most of the studies utilize network-based computational approaches based on drug and disease similarities. However, one common limitation of existing approaches is that both drug similarities and disease similarities are defined based on a single feature of drugs/diseases. In reality, the relationships between drug (or disease) pairs can be characterized based on many different features. Therefore, it is increasingly important to include them in drug repositioning studies. In this study, we propose a flexible and robust multi-source learning (FRMSL) framework to integrate multiple heterogeneous data sources for drug-disease association predictions. We first construct a two-layer heterogeneous network consisting of drug nodes, disease nodes and known drug-disease relationships. The drug repositioning problem can thus be treated as a missing link prediction problem on the heterogeneous graph and can be solved using Kronecker regularized least square (KronRLS) method. Multiple data sources describing drugs and diseases are incorporated into the framework using similarity-based kernels. In practice, a great challenge in such data integration projects is the data incompleteness problem due to the nature of data generation and collection. To address this issue, we develop a novel multi-view learning algorithm based on symmetric nonnegative matrix factorization (SymNMF). Extensive experimental studies show that our framework outperforms several recent network-based methods.

References

[1]
Altshuler, D., Daly, M., and Kruglyak, L. Guilt by association. Nature genetics 26, 2 (2000), 135--138.
[2]
Bleakley, K., and Yamanishi, Y. Supervised prediction of drug--target interactions using bipartite local models. Bioinformatics 25, 18 (2009), 2397--2403.
[3]
Borisy, A. A., Elliott, P. J., Hurst, N. W., Lee, M. S., Lehár, J., Price, E. R., Serbedzija, G., Zimmermann, G. R., Foley, M. A., Stockwell, B. R., et al. Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences 100, 13 (2003), 7977--7982.
[4]
Boyd, S., and Vandenberghe, L. Convex optimization. Cambridge university press, 2004.
[5]
Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., and Bork, P. Drug target identification using side-effect similarity. Science 321, 5886 (2008), 263--266.
[6]
Chen, H., Zhang, H., Zhang, Z., Cao, Y., and Tang, W. Network-based inference methods for drug repositioning. Computational and mathematical methods in medicine 2015 (2015).
[7]
Chiang, A. P., and Butte, A. J. Systematic evaluation of drug-disease relationships to identify leads for novel drug uses. Clinical pharmacology and therapeutics 86, 5 (2009), 507.
[8]
Deng, Y., Gao, L., Wang, B., and Guo, X. Hposim: an r package for phenotypic similarity measure and enrichment analysis based on the human phenotype ontology. PloS one 10, 2 (2015), e0115692.
[9]
Ding, C., He, X., and Simon, H. D. On the equivalence of nonnegative matrix factorization and spectral clustering. In Proceedings of the 2005 SIAM International Conference on Data Mining (2005), SIAM, pp. 606--610.
[10]
Dudley, J. T., Deshpande, T., and Butte, A. J. Exploiting drug--disease relationships for computational drug repositioning. Briefings in bioinformatics (2011), bbr013.
[11]
Gottlieb, A., Stein, G. Y., Ruppin, E., and Sharan, R. Predict: a method for inferring novel drug indications with application to personalized medicine. Molecular systems biology 7, 1 (2011), 496.
[12]
Graul, A., Cruces, E., and Stringer, M. The year's new drugs & biologics, 2013: Part i. Drugs of today (Barcelona, Spain: 1998) 50, 1 (2014), 51--100.
[13]
Greco, F., and Vicent, M. J. Combination therapy: opportunities and challenges for polymer--drug conjugates as anticancer nanomedicines. Advanced drug delivery reviews 61, 13 (2009), 1203--1213.
[14]
Hopkins, A. L. Network pharmacology: the next paradigm in drug discovery. Nature chemical biology 4, 11 (2008), 682--690.
[15]
Li, J., Gong, B., Chen, X., Liu, T., Wu, C., Zhang, F., Li, C., Li, X., Rao, S., and Li, X. Dosim: An r package for similarity between diseases based on disease ontology. BMC bioinformatics 12, 1 (2011), 266.
[16]
Liu, J., Wang, C., Gao, J., and Han, J. Multi-view clustering via joint nonnegative matrix factorization. In Proceedings of the 2013 SIAM International Conference on Data Mining (2013), SIAM, pp. 252--260.
[17]
Luo, H., Wang, J., Li, M., Luo, J., Peng, X., Wu, F.-X., and Pan, Y. Drug repositioning based on comprehensive similarity measures and bi-random walk algorithm. Bioinformatics (2016), btw228.
[18]
Mahé, P., Ralaivola, L., Stoven, V., and Vert, J.-P. The pharmacophore kernel for virtual screening with support vector machines. Journal of Chemical Information and Modeling 46, 5 (2006), 2003--2014.
[19]
Martínez, V., Navarro, C., Cano, C., Fajardo, W., and Blanco, A. Drugnet: Network-based drug--disease prioritization by integrating heterogeneous data. Artificial intelligence in medicine 63, 1 (2015), 41--49.
[20]
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., and Schacht, A. L. How to improve r&d productivity: the pharmaceutical industry's grand challenge. Nature reviews Drug discovery 9, 3 (2010), 203--214.
[21]
Scholkopf, B., and Smola, A. J. Learning with kernels: support vector machines, regularization, optimization, and beyond. MIT press, 2001.
[22]
Smith, T. F., and Waterman, M. S. Identification of common molecular subsequences. Journal of molecular biology 147, 1 (1981), 195--197.
[23]
Steinbeck, C., Hoppe, C., Kuhn, S., Floris, M., Guha, R., and Willighagen, E. L. Recent developments of the chemistry development kit (cdk)-an open-source java library for chemo-and bioinformatics. Current pharmaceutical design 12, 17 (2006), 2111--2120.
[24]
Van Driel, M. A., Bruggeman, J., Vriend, G., Brunner, H. G., and Leunissen, J. A. A text-mining analysis of the human phenome. European journal of human genetics 14, 5 (2006), 535--542.
[25]
van Laarhoven, T., Nabuurs, S. B., and Marchiori, E. Gaussian interaction profile kernels for predicting drug--target interaction. Bioinformatics 27, 21 (2011), 3036--3043.
[26]
Wang, W., Yang, S., and Li, J. Drug target predictions based on heterogeneous graph inference. In Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing (2013), NIH Public Access, p. 53.
[27]
Wang, W., Yang, S., Zhang, X., and Li, J. Drug repositioning by integrating target information through a heterogeneous network model. Bioinformatics 30, 20 (2014), 2923--2930.
[28]
Wu, C., Gudivada, R. C., Aronow, B. J., and Jegga, A. G. Computational drug repositioning through heterogeneous network clustering. BMC systems biology 7, 5 (2013), S6.
[29]
Xie, L., Xie, L., and Bourne, P. E. A unified statistical model to support local sequence order independent similarity searching for ligand-binding sites and its application to genome-based drug discovery. Bioinformatics 25, 12 (2009), i305--i312.endthebibliography

Cited By

View all

Index Terms

  1. A Flexible and Robust Multi-Source Learning Algorithm for Drug Repositioning

    Recommendations

    Comments

    Information & Contributors

    Information

    Published In

    cover image ACM Conferences
    ACM-BCB '17: Proceedings of the 8th ACM International Conference on Bioinformatics, Computational Biology,and Health Informatics
    August 2017
    800 pages
    ISBN:9781450347228
    DOI:10.1145/3107411
    Permission to make digital or hard copies of all or part of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for components of this work owned by others than the author(s) must be honored. Abstracting with credit is permitted. To copy otherwise, or republish, to post on servers or to redistribute to lists, requires prior specific permission and/or a fee. Request permissions from [email protected].

    Sponsors

    Publisher

    Association for Computing Machinery

    New York, NY, United States

    Publication History

    Published: 20 August 2017

    Permissions

    Request permissions for this article.

    Check for updates

    Author Tags

    1. drug repositioning
    2. heterogeneous network
    3. multi-view learning

    Qualifiers

    • Short-paper

    Conference

    BCB '17
    Sponsor:

    Acceptance Rates

    ACM-BCB '17 Paper Acceptance Rate 42 of 132 submissions, 32%;
    Overall Acceptance Rate 254 of 885 submissions, 29%

    Contributors

    Other Metrics

    Bibliometrics & Citations

    Bibliometrics

    Article Metrics

    • Downloads (Last 12 months)18
    • Downloads (Last 6 weeks)6
    Reflects downloads up to 13 Jan 2025

    Other Metrics

    Citations

    Cited By

    View all

    View Options

    Login options

    View options

    PDF

    View or Download as a PDF file.

    PDF

    eReader

    View online with eReader.

    eReader

    Media

    Figures

    Other

    Tables

    Share

    Share

    Share this Publication link

    Share on social media